BALYASNY ASSET MANAGEMENT L.P. - AMICUS THERAPEUTICS INC ownership

AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 223 filers reported holding AMICUS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.56 and the average weighting 0.3%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of AMICUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$41,166,853
+1.6%
3,385,432
+5.0%
0.08%
-5.6%
Q2 2023$40,506,414
+72.4%
3,225,033
+52.2%
0.09%
+50.8%
Q1 2023$23,495,363
-3.8%
2,118,608
+5.9%
0.06%
-11.9%
Q4 2022$24,418,241
+38.8%
1,999,856
+18.7%
0.07%
+24.1%
Q3 2022$17,591,000
-23.9%
1,684,968
-21.7%
0.05%
-28.0%
Q2 2022$23,124,000
+17286.5%
2,153,084
+15886.7%
0.08%
+7400.0%
Q1 2021$133,000
-59.1%
13,468
-41.4%
0.00%
-50.0%
Q3 2020$325,000
+66.7%
22,984
+78.2%
0.00%
+100.0%
Q3 2017$195,000
-91.4%
12,900
-94.3%
0.00%
-88.9%
Q2 2017$2,269,000
+38.5%
225,314
-24.9%
0.01%
-18.2%
Q2 2016$1,638,000
+2.0%
300,000
+57.9%
0.01%
+10.0%
Q1 2016$1,606,000
-89.7%
190,044
-86.8%
0.01%
-92.1%
Q1 2015$15,631,000
+26.5%
1,436,694
-3.2%
0.13%
+11.5%
Q4 2014$12,354,000
+2973.1%
1,484,809
+664.7%
0.11%
+2160.0%
Q1 2014$402,000
-66.6%
194,163
-62.1%
0.01%
-68.8%
Q4 2013$1,204,000
+6.6%
512,284
+5.2%
0.02%
+6.7%
Q3 2013$1,129,000
+21.1%
486,785
+21.7%
0.02%
-6.2%
Q2 2013$932,000400,0000.02%
Other shareholders
AMICUS THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Palo Alto Investors LP 10,114,043$116,817,0007.46%
Parametrica Management Ltd 597,279$6,899,0006.86%
Redmile Group, LLC 22,716,086$262,371,0005.96%
Perceptive Advisors 53,118,886$613,524,0004.73%
Asymmetry Capital Management, L.P. 716,709$8,278,0004.39%
CM Management, LLC 450,000$5,198,0003.93%
Avoro Capital Advisors LLC 18,500,000$213,675,0003.64%
Kynam Capital Management, LP 573,699$6,626,0003.54%
SECTORAL ASSET MANAGEMENT INC 1,242,882$14,355,0002.16%
Ghost Tree Capital, LLC 500,000$5,775,0002.07%
View complete list of AMICUS THERAPEUTICS INC shareholders